563.1000 -1.85 (-0.33%)
NSE Jan 01, 2026 15:53 PM
Volume: 38,667
 

563.10
-0.33%
Axis Direct
We expect the whole API industry to continue facing challenges due to a fall in realization as well as an increase in cost pressure. We foresee the situation to continue for the next 2-3 quarters and therefore recommend a HOLD rating on the stock with the target price of Rs 1,300/share.
Promoters unpledged 3.63% of shares in last quarter. Total pledge stands at 35.32% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended